Abstract
Background and Aims
Hyperglycaemia among newborn infants is becoming an increasingly important clinical problem encountered in many neonatal units as survival of very low birth weight (VLBW) infants continues to improve. This is because hyperglycaemia has been linked to increased morbidities and mortality among them [1, 2] . For instance, every 1 mmol/L (18 mg/dl) rise in blood glucose causes an increase in serum osmolality of 1 mOsm/L [3] . Some morbidities that have been associated with osmolar changes in neonatal hyperglycaemia include dehydration, serum electrolyte derangement, and cerebral damage/haemorrhage [3, 4] . Hyperglycaemia is usually discovered incidentally on routine blood glucose assessment or in response to finding glycosuria. Although most affected neonates are asymptomatic, some recognizable signs include dehydration due to osmotic diuresis, weight loss, failure to thrive, fever, glycosuria, ketosis, and metabolic acidosis. The latter three signs are particularly common among infants who have transient or permanent neonatal diabetes mellitus [5] .
Considering the association between hyperglycaemia and increased morbidity and mortality, there is the need for prevention, early detection and sometimes, therapeutic intervention.
The definition of neonatal hyperglycaemia remains debatable [6, 7] . However, whole blood glucose ≥ 7 mmol/L (≥126mg/dl) or plasma glucose ≥ 8.3 mmol/L (≥150mg/dl) has been suggested as a reasonable cut-off point, regardless of the neonate's gestational age, weight or postnatal age; this representing the renal threshold of healthy preterm infants [5, 8] . It must be appreciated that these definitions are based on statistical studies that do not take into account the biologic variability or underlying hypoxic or ischaemic events that have the potential to alter the infant's response to exogenous glucose. It has been documented that mildly elevated blood glucose levels may be detrimental in small preterm infants, particularly in the presence of hypoxic or ischaemic insults during birth [3] . Even among healthy term babies, whole blood glucose levels above7 mmol/L are considered unusual [9] .
Hyperglycaemia frequently occurs in preterm, very low birthweight infants due to clinical stress, resulting in an increased hepatic gluconeogenesis as well as a reduction in insulin sensitivity. [5, 9] Other mechanisms include reduced ability to produce insulin [8] , defective beta-cell processing of proinsulin (which is 10 to 16 times less active than insulin) to insulin [10] , and inability to suppress hepatic glucose production in response to glucose infusion [11] .
Established common causes of neonatal hyperglycaemia include iatrogenic (from excessive intravenous glucose delivery), impaired glucose homeostasis in preterm/ Smallfor-Gestational Age infants, sepsis, respiratory distress syndrome, and drugs, particularly corticosteroids. Rare causes include transient neonatal diabetes, permanent neonatal diabetes and pancreatic agenesis [3, 7] . In Nigeria, volumetric pumps capable of providing, at a steady rate, very small amounts of intravenous fluid containing glucose are largely non-existent, even in tertiary-healthcare hospitals. Thus, making intravenous fluid therapy a potential source of iatrogenic hyperglycaemia.
The prevalence rate of neonatal hyperglycaemia is highly variable, depending on gestational age and birthweight. The reported prevalence varies from 32 to 86% in VLBW infants [9, 12] . On the other hand, Nalini et al [13] found a low prevalence of 2.9% in VLBW infants. Other factors that may influence the prevalence in VLBW infants include the presence of stress and the amount of glucose infused per unit time [3, 12] . Previous studies revealed that majority (70.0%) of cases of hyperglycaemia occur in the first 24 hours of life [13, 14] . In Nigeria, and perhaps most developing countries, documentation of the frequency of hyperglycaemia occurring with or complicating primary illnesses is scarce. A similar observation has been noted by Obasa et al [15] . This paucity of data on the subject prompted the present study.
The present study, therefore, sought to determine the prevalence of hyperglycaemia among very low birth weight (defined as birth weight < 1500g) infants admitted into the Special Care Baby Unit of a secondaryhealthcare institution in Nigeria and describe their clinical characteristics. It is hoped that the study will provide the essential data for the management and planning of services for the prevention, control and treatment of VLBW infants with regard to blood glucose status.
Material and Methods
In this retrospective study, the charts of all inborn very low birth weight infants who were admitted into the Special Care Baby Unit (SCBU) of St Philomena Catholic Hospital (SPCH), Benin City, Nigeria between 1st January, 2010 and 31st December, 2011 were retrieved and reviewed. SPCH is a large secondary healthcare institution located in the centre of the Benin City, the capital of Edo State. In this neonatal unit, care is provided by a consultant paediatrician, five medical officers (each with more than five years experience) and 15 trained staff nurse/midwives. The neonatal unit has three functional incubators, one oxygen concentrator and oxygen cylinders which are regularly full. The hospital has a moderately equipped medical laboratory that offers a 24-hour service by qualified medical laboratory scientists. Ultrasonography and radiography services are provided by a consultant Radiologist and an Ultrasonologist. Permission for the study was obtained from the hospital authority. The relevant case notes were retrieved from the records department and reviewed. Information obtained from the charts included birth weight, gestational age (best obstetric record), gender, types and rates of intravenous fluid administration, presence or absence of septicaemia, maternal medical disorders in pregnancy, and the infant outcome (defined as death or survival in the first 96 hours of life). In this neonatal unit, blood glucose concentrations were measured as a routine, three times daily (8 hourly) for each VLBW infant, using an Accutrend glucometer that displays blood glucose reading in mmol/L. Oral feeding was given where the infant's clinical condition permits. From the charts we noted the highest and the lowest blood glucose values and calculated the mean daily blood glucose concentration for each of the infants for the first 96 hours of life. The prevalence rates of hyperglycaemia on each day of the first 96 hours of life were calculated and categorized into mild, moderate and severe, respectively. The mean rate of glucose infusion (g/kg/hr) from point of admission was computed in each case and related to the blood glucose level. When hyperglycaemia was detected, the rate of infusion or concentration of glucose in the intravenous fluid was reduced and the blood glucose re-checked one hour later in accordance with the guidelines of this unit. Insulin was not administered to any of the hyperglycaemic infants. In the present study, infants with blood glucose value ≥ 7 mmol/L on two occasions were considered to have hyperglycaemia. Hyperglycaemia was categorized into mild (blood glucose 7-9.9 mmol/L); moderate (blood glucose 10-15 mmol/L); and severe (blood glucose > 15 mmol/L).
Statistical analysis
Descriptive statistics such as frequencies, means, odds ratios, standard deviations, confidence intervals, and percentages were used in describing all the variables. The chi-square test and Z-test were used in ascertaining the significance of differences between two proportions while Student's t test was used in the case of two means with the p-value set at <0.05.
Results
During the period covered by this review, 120 very low birth weight (VLBW) infants were admitted into the neonatal unit of the hospital. Of this number, the records of 14 cases were incomplete and were excluded. Thirteen (12.3%) of the remaining 106 cases died within the first 96 hours of life. Five (38.5%) of the 13 babies who died had hyperglycaemia before demise. All the study infants were inborn and their mothers received antenatal care in SPCH. The overall mean gestational age was 29.3±1.5 weeks, 95% confidence interval, CI = 29.0 -29.6 weeks. The overall mean birth weight was 1050±180 g; 95% CI = 1013 -1087 g.
A total of 279 blood glucose values were available for the 93 infants who survived the first 96 hours of life with 128 (45.9%) of these values being ≥ 7mmol/L in one occasion. In addition, 91 (32.6%; 95% CI = 27.1% -38.1%) blood glucose values were ≥ 7mmol/ on two occasions (defining hyperglycaemia). Of these 91 blood glucose values, 17(18.7%) were greater than 15 mmol/L (severe hyperglycaemia). Glycosuria accompanied 12(13.2%) of these 91 blood glucose values but resolved after reduction in rate and/or concentration of dextrose-containing intravenous fluid with none of them requiring insulin therapy. The blood glucose values of the hyperglycaemic infants ranged between 8.5 and 16.7 mmol/L. As shown in Table 1 , there was a three-fold increase in the risk of hyperglycaemia in infants whose mothers had a positive history of chorioamnionitis. The mean gestational age was significantly lower in hyperglycaemic compared with normoglycaemic infants (Table 1) . From the 91 blood glucose values in the hyperglycaemic range, 56 (61.5%) occurred in the first 48 hours of life. The distribution of blood glucose values in the hyperglycaemic range according to postnatal age (hours) of the infants is depicted in Table 2 . To allow for ease of understanding and comparison between the present study and previous ones, Table 3 compared the common methods of expressing glucose infusion rate with the method used in this study. Of the 93 infants who survived the first 96 hours of life, 42(45.2%) had 10% DW at a rate of < 0.4g/kg/hr while the remaining 51(54.8%) had 10% DW at a rate of > 0.4g/kg/hr. Comparing the frequency of hyperglycaemia among infants with rate of infusion of 10% DW < 0.4g/kg/hr and those with rate ≥ 0.4g/kg/hr, it was 31.0% (13/42) versus 62.7% (32/51); Odds ratio, OR = 3.76 (95% CI= 1.58-8.94).
Discussion
In the present study, slightly over one-third (32.6%) of the blood glucose values were in the hyperglycaemic range. This is not surprising as it falls within the prevalence rate of 32% to 86% reported from other studies among very low birth weight (VLBW) infants [8, 12] . Although the frequency found in the present study falls within this range, it represents a wide variation. The wide variation may be a reflection of the fragile nature of glucose metabolism in VLBW infants. This view was also held in previous reports on the subject but the mechanism remains debatable [8] [9] [10] [11] 16 ]. The frequent occurrence of hyperglycaemia among VLBW infants has been attributed to inability to suppress hepatic glucose production in response to glucose infusion [11] and a reduction in insulin sensitivity [9] . However, the present study was not designed to assess the mechanism of hyperglycaemia.
As in previous studies [17, 18] , the frequency of hyperglycaemia had a significant bearing with gestational age. The lower the gestational age the higher the frequency of hyperglycaemia. The same relationship tends to holds true for birthweight. The relatively higher frequency of hyperglycaemia in preterm VLBW infants suggests that the glucose metabolism is more fragile in this group of infants. Therefore, they require a close monitoring of their blood glucose status. The clinical importance of this monitoring is documented in the report of Hemachandra and Cowett [5] . In that report, they stated that if serum osmolarity exceeds 300 mOsm/L (approximately a serum glucose value of 22.2 mmol/L; 400 mg/dl) rapidly shifting water may cause cerebral haemorrhage, particularly if it persists for up to 5 hours. The clinical implication is that apparently transient hyperglycaemia in preterm VLBW infants may be injurious to the infant. In our study, there was a higher frequency of hyperglycaemia among infants with a positive history of maternal chorioamnionitis, indirectly suggesting that sepsis might be a risk factor for hyperglycaemia in these infants. This is not surprising as sepsis in preterm VLBW infants has been observed as a risk factor for hyperglycaemia [3, 7, 8] .The clinical implication is that blood glucose level should be monitored closely in all VLBW infants, particularly if a history of maternal chorioamnionitis was present.
The frequency of hyperglycaemia was almost four times higher in infants whose infusion rate was greater than 0.4g/kg/hour compared with their counterparts with a lower rate. This might imply that this rate of dextrose infusion exceeds the maximum rate of glucose utilization in these infants with limited metabolic capacity. The quantity of infused glucose that VLBW infants tolerate varies. Infusing dextrose at 5mg/kg/min (equivalent to 0.3g/kg/hr) and advancing gradually over several days may reduce intolerance, preventing the consequences (serum hyperosmolarity and osmotic diuresis) of acute intolerance to glucose [19] . Fetal glucose production rate is approximately 5mg/kg/minute [7] . In most adults, the maximum rate of glucose utilization is between 0.8 to 1.0g glucose per kilogram body weight per hour [20] . The association between hyperglycaemia and the rate of dextrose infusion has been reported previously [14] . In contrast, Beardsall et al [12] did not find any association between the rate of dextrose infused and occurrence of hyperglycaemia. The usual minimum infusion rate with a drip chamber is approximately 5 ml/hour [14] , suggesting that infusion pumps are essential in VLBW infants for accurate delivery of these low glucose infusion rates. Considering that most health facilities in Nigeria lack infusion pumps, monitoring of blood glucose becomes a sine qua non in the management of VLBW infants. Although cerebral haemorrhage is a major hazard of hyperglycaemia in VLBW infants, excess water loss secondary to osmotic diuresis is equally a serious morbidity that needs to be avoided. The blood glucose values returned toward normal limits following reduction in the rate of infusion and/or concentration of glucose in the intravenous fluid. In this series, none of the infants with hyperglycaemia required insulin or sulfonylurea therapy (as the condition resolved with reduction of infusion rate or concentration of glucose), suggesting that they were not cases of neonatal diabetes mellitus. The diagnosis of neonatal diabetes requires that hyperglycaemia must persist for at least two weeks [21] .
Although the risk of hyperglycaemia tended to be higher in the first 48 hours of life, it was not statistically significant. This is in general agreement with the report of a previous study [14] . The implication of the temporal effect is that there is a reduced glucose tolerance to an acute load of glucose in the first few days of life, indicating the need for close monitoring of blood glucose during this period.
One limitation of the present study was its inability to assess the effect of different primary illnesses on the prevalence of neonatal hyperglycaemia. Another limitation was the use of a glucometer rather than the standardized biochemistry analyzer for the measurement of the blood glucose values. This fact needs to be borne in mind when interpreting the data, given that errors of glucometer blood glucose readings are common. Despite this limitation, the study gave an insight into the prevalence rate of hyperglycaemia among VLBW infants and identified some of the risk factors.
Conclusion
In conclusion, in the first 48 hours of life, hyperglycaemia co-existing with or complicating primary illnesses was common in VLBW infants who had dextrose infusion and a positive history of maternal chorioamnionitis. It is, therefore, reasonable to recommend that blood glucose levels in such infants should be monitored regularly, thus enabling clinicians to individualize glucose requirements.
